Ads
related to: acute myeloid leukemia
Search results
In the news | Northwest Arkansas Democrat-Gazette
Northwest Arkansas Democrat Gazette· 7 hours agoAsma Assad, wife of Syrian President Bashar Assad, was diagnosed with acute myeloid leukemia -- an aggressive cancer of the bone marrow ...
Syrian first lady Asma Assad diagnosed with leukemia, president's office says
Associated Press via Yahoo News· 1 day agoSyrian first lady Asma Assad has been diagnosed with leukemia, the office of President Bashar Assad...
Benzene Exposure Linked to Acute Myeloid Leukemia, Aplastic Anemia, and Lymphomas | JD Supra
JD Supra· 5 days agoIf you have been diagnosed with acute myeloid leukemia but cannot figure out why, benzene may be responsible. Benzene, a chemical used ...
Earnings call: Aptose Biosciences targets AML treatment with tuspetinib By Investing.com
Investing.com· 7 days agoAptose Biosciences (NASDAQ:APTO) has focused its efforts on developing tuspetinib as part of a novel...
MD Anderson Research Highlights for May 21, 2024 | Newswise
Newswise· 1 day agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These
Moleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA)...
WTRF Wheeling· 6 days agoMoleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses ...
Q1 2024 Exscientia PLC Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 11 hours agoToday, we are providing updates for our highly differentiated LSD1 inhibitor the XS74539, or 539, which continues its progression towards a Phase 1 clinical trial in acute ...
Local Leukemia & Lymphoma Society holds annual fundraiser for blood cancer research
Local 12 Cincinnati· 6 days agoThe local chapter of the Leukemia and Lymphoma Society held its annual fundraiser to raise money for...
Aileron Therapeutics (NASDAQ:ALRN) Announces Earnings Results, Misses Estimates By $0.72 EPS
ETF DAILY NEWS· 8 hours agoAileron Therapeutics (NASDAQ:ALRN – Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.86) EPS for the quarter, missing the consensus estimate of ($0.14 ...
Earnings call: Bio-Path Holdings reports promising Q1 2024 results By Investing.com
Investing.com· 7 days agoBio-Path Holdings (NASDAQ: NASDAQ:BPTH), a biotechnology company focused on developing therapeutic...
Ad
related to: acute myeloid leukemia
